All Stories

  1. High cytotoxicity of a degraded TBBPA, dibromobisphenol A, through apoptotic and necrosis pathways
  2. Metal ion scavenging activity of elastin-like peptide analogues containing a cadmium ion binding sequence
  3. Direct evidence of edge-to-face CH/π interaction for PAR-1 thrombin receptor activation
  4. Bisphenol A derivatives act as novel coactivator-binding inhibitors for estrogen receptor β
  5. Simple Regulation of the Self-Assembling Ability by Multimerization of Elastin-Derived Peptide (FPGVG)n Using Nitrilotriacetic Acid as a Building Block
  6. Bisphenol-C is the strongest bifunctional ERα-agonist and ERβ-antagonist due to magnified halogen bonding
  7. Mechanistic Insights into a DMSO-Perturbing Inhibitory Assay of Hyaluronidase
  8. Evaluation of the Influence of Halogenation on the Binding of Bisphenol A to the Estrogen-Related Receptor γ
  9. Bisphenol AF: Halogen bonding effect is a major driving force for the dual ERα-agonist and ERβ-antagonist activities
  10. Early identification of promiscuous attributes of aldose reductase inhibitors using a DMSO-perturbation assay
  11. Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors
  12. DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors
  13. Importance of Receptor Conformations in Docking Calculation-Based Risk Assessment for Endocrine Disruptors against Estrogen Receptor α
  14. Simple Cyclization of ELP: Strong Self-Aggregation Properties of Cyclo[FPGVG]n,
  15. The water-soluble elastin as a functional food to exert a blood pressure-lowering effect
  16. Stepwise mechanism of temperature-dependent coacervation of short dimer ELP
  17. Multifunctional biological activities of water extract of housefly larvae ( Musca domestica )
  18. Role of individual disulfide bridges in the conformation and activity of spinoxin (α-KTx6.13), a potassium channel toxin from Heterometrus spinifer scorpion venom
  19. Active Sites of Spinoxin, a Potassium Channel Scorpion Toxin, Elucidated by Systematic Alanine Scanning
  20. Highly coacervatable 5-mer elastin peptide repeat-dimers developed
  21. (WPGVG)3 exhibiting temperature‐dependent self‐assembly activity
  22. Design of Phenylalanine-Containing Elastin-Derived Peptides Exhibiting Highly Potent Self-Assembling Capability
  23. Potent coacervation property of Ile-containing elastin-derived peptide
  24. Highly potent binding and inverse agonist activity of bisphenol A derivatives for retinoid-related orphan nuclear receptor RORγ
  25. Fine spatial assembly for construction of the phenol-binding pocket to capture bisphenol A in the human nuclear receptor estrogen-related receptor  
  26. Structural requirements essential for elastin coacervation: favorable spatial arrangements of valine ridges on the three-dimensional structure of elastin-derived polypeptide (VPGVG)n
  27. Spare interactions of highly potent [Arg14,Lys15]nociceptin for cooperative induction of ORL1 receptor activation
  28. Exploration of endocrine-disrupting chemicals on estrogen receptor α by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-Adamantyl)phenol as a potent endocrine disruptor candidate
  29. Discriminatory synergistic effect of Trp-substitutions in superagonist [(Arg/Lys)14, (Arg/Lys)15]nociceptin on ORL1 receptor binding and activation
  30. Synergistic effect of basic residues at positions 14–15 of nociceptin on binding affinity and receptor activation
  31. Radar Chart Deviation Analysis of Prion Protein Amino Acid Composition Defines Characteristic Structural Abnormalities of the N-Terminal Octapeptide Tandem Repeat
  32. Estimation of binding potency of bisphenol A against estrogen-related receptor gamma
  33. Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist
  34. Differential receptor binding characteristics of consecutive phenylalanines in μ-opioid specific peptide ligand endomorphin-2
  35. cDNA cloning of the housefly pigment-dispersing factor(PDF) precursor protein and its peptide comparison among the insect circadian neuropeptides
  36. Molecular cloning and circadian expression profile of insect neuropeptide PDF in black blowfly,Phormia regina
  37. Site-directed affinity-labeling of delta opioid receptors by SNpys-containing enkephalin and dynorphin analogues
  38. Aggregation Feature of Fluorine-Substituted Benzene Rings and Intermolecular C–H···F Interaction: Crystal Structure Analyses of Mono- and Trifluoro-L-phenylalanines
  39. Characterization, primary structure and molecular evolution of anticoagulant protein from Agkistrodon actus venom
  40. Structural requirements of nociceptin antagonist Ac-RYYRIK-NH2 for receptor binding
  41. Receptor Binding Site of Arg-Lys Triple Repeat in Nociceptin Superagonist
  42. Structural essentials of xenoestrogen dialkyl phthalates to bind to the estrogen receptors
  43. The Role of Deltorphin II Phenylalanine Residue in Binding to theδOpioid Receptor
  44. Exploration of the Role of Phenylalanine in the Thrombin Receptor Tethered-Ligand Peptide by Substitution with a Series of Trifluorophenylalanines
  45. Highly Potent Nociceptin Analog Containing the Arg-Lys Triple Repeat
  46. Head-to-Tail Polymerization of Coagulin, a Clottable Protein of the Horseshoe Crab
  47. Edge-to-Face CH/"" Interaction between Ligand Phe-Phenyl and Receptor Aromatic Group in the Thrombin Receptor Activation
  48. Synthesis of a complete set of l-difluorophenylalanines, l-(F2)Phe, as molecular explorers for the CH/π interaction between peptide ligand and receptor
  49. Effects of Substitution of Hydrophobic Amino Acids by Tryptophan on Receptor Binding and Biological Activity of Neuropeptide Nociceptin
  50. Design and Synthesis of para-Fluorophenylalanine Amide Derivatives as Thrombin Receptor Antagonists
  51. Exploration of Universal Cysteines in the Binding Sites of Three Opioid Receptor Subtypes by Disulfide-Bonding Affinity Labeling with Chemically Activated Thiol-Containing Dynorphin A Analogs
  52. A novel molecular design of thrombin receptor antagonist
  53. Design of serine protease inhibitors with conformation restricted by amino acid side-chain-side-chain CH/? interaction
  54. Interaction Mode of the Phe-Phenyl Group of Thrombin Receptor-Tethered Ligand SFLLRNP in Receptor Activation
  55. The Role of Arginine in Thrombin Receptor Tethered-Ligand Peptide in Intramolecular Receptor Binding and Self-Activation
  56. X-ray crystal structure of a dipeptide-chymotrypsin complex in an inhibitory interaction
  57. Sensitivity of Opioid Receptor-like Receptor ORL1 for Chemical Modification on Nociceptin, a Naturally Occurring Nociceptive Peptide
  58. Reversible Affinity Labeling of Opioid Receptors via Disulfide Bonding: Discriminative Labeling of   and   Subtypes by Chemically Activated Thiol-Containing Enkephalin Analogs
  59. Chymotrypsin Inhibition Induced by Side Chain-Side Chain Intramolecular CH/  Interaction in D-Thr-L-Phe Benzylamide
  60. Chymotrypsin inhibitory conformation induced by amino acid side chain–side chain intramolecular CH/π interaction
  61. Different Roles of Two Consecutive Leucine Residues in a Receptor-Tethered Ligand Peptide (SFLLRNP) in Thrombin Receptor Activation
  62. Purification and characterization of a coagulant enzyme, okinaxobin II, from Trimeresurs okinavensis (himehabu snake) venom which releases fibrinopeptides A and B
  63. Differential Roles of Two Consecutive Phenylalanine Residues in Thrombin Receptor-Tethered Ligand Peptides (SFFLRNP) in Thrombin Receptor Activation
  64. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase.
  65. Structural Essentials of Ser-1 in Tethered Peptide Ligand of Human Thrombin Receptor for Phosphoinositide Hydrolysis
  66. Purification, sequencing and characterization of single amino acid-substituted phospholipase A2 isozymes from Trimeresurus Gramineus (green habu snake) venom
  67. Chymotrypsin inhibitory conformation of dipeptides constructed by side chain-side chain hydrophobic interactions
  68. Enhancement of Thrombin Receptor Activation by Thrombin Receptor-Derived Heptapeptide with para-Fluorophenylalanine in Place of Phenylalanine
  69. Thrombin acceptor which contains ligand.
  70. Importance of phenylalanine residue in the tethered peptide ligand for self-activation of the thrombin receptor
  71. Occurrence of an allosteric transition in the modification of papain withl-1-acetyl-2,3-dihydropyrrolo[2,3-b]-indole-2-carboxamide